Coronary intervention for persistent occlusion after myocardial infarction.
By Judith Hochman, G. Lamas, C. Buller, V. Džavík, H. Reynolds, S. Abramsky, S. Forman, W. Rużyłło, A. Maggioni, Harvey D. White and 12 more. New England Journal of Medicine, 2006
691 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/9a8f207c17371acc420d0cbc40fceb2aa5fee766
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Pathology and Forensic Medicine
In Surgery
Citations in the corpus
- Guidelines on myocardial revascularization. (2010, background): “benefit from PCI [90,91].”
- 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. (2008, background): “OSCA-2 (Total Occlusion Study of Canada) (13) enolled 381 stable patients in a mechanistic ancillary study of AT and had the same eligibility criteria (12).”
- 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008, methodology): “Sabatine MS et al. (9); Bennett JS et al. (10); Smith SC Jr et al. (11); OAT (12, 13 ) and TOSCA (14)].”
- 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008, methodology): “TOSCA-2 (Total Occlusion Study of Canada)(14) enrolled 381 stable patients in a mechanistic ancillary study of OAT and had the same eligibility criteria.(12,13) The PCI procedure success rate was 92% and the complication rate was 3%, although 9% had periprocedural MI as measured by cardiac biomarker”